• Tue, April 22, 2025

by: MoneyWeek

Is investing in AIM still worth it after IHT clampdown?

HMRC expects to rake in £110 million a year from upcoming inheritance tax changes on AIM shares. The tax relief will be cut from April 2026, meaning you could find yourself paying 20% in inheritance tax.

by: CNN

Stocks rebound as US Treasury Secretary says China trade war is unsustainable

Treasury Secretary Scott Bessent told investors Tuesday that the US-China trade war is unsustainable and he expects the battle to de-escalate, a person familiar with the matter confirmed to CNN, giving a boost to a Wall Street rally that had taken shape this morning.

by: FXStreet

Bitcoin shows weakness in 2025 amid its decoupling from Gold and the US Dollar's steep decline

Bitcoin is down over 6% in 2025 despite the US Dollar sustaining a YTD loss of 9%. The top crypto and Gold have historically rallied during periods of Dollar weakness, with BTC posting average gains of 43%. The EXY has also reversed its losses since January at the expense of Bitcoin, US stocks and the DXY.

by: Fortune

What to believe, Elon Musk's promises or Tesla terrible results for Q1?

Elon Musk's true believers are boosting the stock after market despite a big net income drop.

by: Investopedia

Markets News, April 22, 2025: Stocks Surge as Market Bounces Back From Sell-Off; Bitcoin Jumps Above $92,000

Stocks closed sharply higher Tuesday, recovering all of the ground lost during yesterday's downturn, as investors digested a flurry of earnings reports and awaited further developments on tariffs.

by: Newsfile

Biopharma Stocks Transformative Innovation for the Future of Health

Vancouver, Kelowna and Delta, British Columbia--(Newsfile Corp. - July 11, 2024) - Investorideas.com, a go-to investing platform releases the first of a two-part series looking at transformative innovation in biopharma, featuring Citius Pharmaceuticals, Inc. (NASDAQ: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products. The Company's diversified pipeline includes two late-stage product candidates.Read the full a

by: WOPRAI

Short squeeze is starting in shares of VBNK at $11.09, after crossing above the $11.079 Trigger Price

by: CNBC

Tuesday's market rally shows Wall Street wants Trump to embrace 'the art of the backpedal'

Stocks jumped on Tuesday, boosted by news that Treasury Secretary Scott Bessent said he expects de-escalation in the tariff standoff with China.

by: Fortune

Stock market rallies after closed-door remarks by Treasury Secretary Bessent

The S&P 500 climbed 2.5% after a broad market selloff on Monday.

by: CNBC

Jim Cramer touts his favorite stock in the portfolio, says it's being overlooked

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

by: Investopedia

What Your Attachment to Nvidia and Apple Stocks Could Reveal About Your Investing Psychology

Your obsession with certain stocks might reveal investing biases that are hurting your returns. Learn how emotional attachments to popular tech stocks can hurt your returns, and discover practical strategies to make more rational investment decisions.

by: WOPRAI

Short squeeze is starting in shares of ORRF at $27.61, after crossing above the $27.46 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of CCNE at $21.86, after crossing above the $21.817 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of SEAS at $44.96, after crossing above the $44.633 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of OCUL at $7.92, after crossing above the $7.867 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of LITB at $2.06, after crossing above the $2.049 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of PKBK at $18.94, after crossing above the $18.796 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of TYGO at $0.848, after crossing above the $0.823 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of SN at $75.055, after crossing above the $74.993 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of RGCO at $21.57, after crossing above the $21.556 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of NTES at $102.685, after crossing above the $102.479 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of COYA at $6.69, after crossing above the $6.572 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of BTE at $1.715, after crossing above the $1.714 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of VEEV at $215.14, after crossing above the $214.517 Trigger Price

  • Wed, April 23, 2025

by: WOPRAI

As of Apr 23rd, 2025, there has been substantial selling of New World Development Company Limited in recent trading

by: WOPRAI

As of Apr 23rd, 2025, there has been substantial selling of OneMedNet Corporation in recent trading

by: WOPRAI

As of Apr 23rd, 2025, there has been substantial selling of Norden Crown Metals Corp. in recent trading

by: WOPRAI

As of Apr 23rd, 2025, there has been substantial selling of Oblong, Inc. in recent trading

by: WOPRAI

As of Apr 23rd, 2025, there has been substantial selling of Patriot National Bancorp, Inc. in recent trading

by: WOPRAI

As of Apr 23rd, 2025, there has been substantial selling of Ameriguard Security Services, Inc. in recent trading

by: WOPRAI

As of Apr 23rd, 2025, there has been substantial selling of Kelyniam Global, Inc. in recent trading

by: WOPRAI

As of Apr 23rd, 2025, there has been substantial selling of Stratos Renewables Corporation in recent trading

by: WOPRAI

As of Apr 23rd, 2025, there has been substantial selling of MicroCloud Hologram Inc. in recent trading

by: WOPRAI

As of Apr 23rd, 2025, there has been substantial selling of Propanc Biopharma, Inc. in recent trading

by: WOPRAI

As of Apr 23rd, 2025, there has been substantial selling of Algoma Steel Group Inc. in recent trading

by: WOPRAI

As of Apr 23rd, 2025, there has been substantial selling of Almadex Minerals Ltd in recent trading

by: WOPRAI

As of Apr 23rd, 2025, there has been substantial selling of Liberty Star Uranium & Metals Corp. in recent trading

by: WOPRAI

As of Apr 23rd, 2025, there has been substantial selling of Syrah Resources Limited in recent trading

by: WOPRAI

As of Apr 23rd, 2025, there has been substantial selling of iBio, Inc. Common Stock in recent trading

by: WOPRAI

As of Apr 23rd, 2025, there has been substantial selling of A SPAC III Acquisition Corp in recent trading

by: WOPRAI

As of Apr 23rd, 2025, there has been substantial selling of Ohmyhome Limited in recent trading

by: WOPRAI

As of Apr 23rd, 2025, there has been substantial selling of Northwest Biotherapeutics, Inc. in recent trading

by: WOPRAI

As of Apr 23rd, 2025, there has been substantial selling of Tivic Health Systems, Inc. in recent trading

by: WOPRAI

As of Apr 23rd, 2025, there has been substantial selling of Viewbix Inc. in recent trading

by: WOPRAI

As of Apr 23rd, 2025, there has been substantial selling of Kingboard Laminates Holdings Limited in recent trading

by: WOPRAI

As of Apr 23rd, 2025, there has been substantial selling of in recent trading

by: WOPRAI

As of Apr 23rd, 2025, there has been substantial selling of Jayud Global Logistics Limited in recent trading

by: WOPRAI

As of Apr 23rd, 2025, there has been substantial selling of CS Diagnostics Corp in recent trading

Is investing in AIM still worth it after IHT clampdown?

HMRC expects to rake in £110 million a year from upcoming inheritance tax changes on AIM shares. The tax relief will be cut from April 2026, meaning you could find yourself paying 20% in inheritance tax.
The article from MoneyWeek discusses the potential benefits and risks of investing in AIM (Alternative Investment Market) shares to mitigate inheritance tax (IHT). AIM shares can qualify for Business Property Relief (BPR) if held for at least two years, which can exempt them from IHT, making them an attractive option for reducing tax liabilities on estates. However, the article cautions that AIM investments are inherently riskier than mainstream investments due to their association with smaller, less established companies. It highlights that while the tax benefits can be significant, the volatility and potential for loss in AIM shares mean they are not suitable for all investors. The piece advises considering one's risk tolerance and financial situation before investing in AIM shares for IHT planning, and suggests consulting with a financial advisor to tailor such strategies to individual needs.

Read the Full MoneyWeek Article at:
https://moneyweek.com/personal-finance/inheritance-tax/aim-inheritance-tax-worth-it